Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Remarks:
Comparable to guideline study. Well documented study which meets basic scientific principles.

Data source

Reference
Reference Type:
publication
Title:
Comparative acute toxicity and primary irritancy of the ethylidene and vinyl isomers of norbornene.
Author:
Ballantyne B, Myers R and Klonne D.
Year:
1997
Bibliographic source:
J. Applied Toxicology 17, 211-221.

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Principles of method if other than guideline:
Method not specified
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
5-vinylnorborn-2-ene
EC Number:
221-259-8
EC Name:
5-vinylnorborn-2-ene
Cas Number:
3048-64-4
Molecular formula:
C9H12
IUPAC Name:
5-ethenylbicyclo[2.2.1]hept-2-ene
Constituent 2
Reference substance name:
5-vinyl-2-norbornene
IUPAC Name:
5-vinyl-2-norbornene
Details on test material:
- Test substance: 5-vinyl-2-norbornene (CAS 3048-64-4)
- Purity: >99%
- Source: Union Carbide Corporation, South Charleston, West Virginia

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure:
whole body
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Vapour produced by metered piston pump delivering liquid into a heated evaporator at 40-50C
- Exposure chamber volume: 1300litre
- Method of holding animals in test chamber:
- Source and rate of air: 250litre/min
TEST ATMOSPHERE
- Brief description of analytical method used: gas sampler and GC/FID every 5 minutes. Nominal concentrations based on mass volume consumed.
- Samples taken from breathing zone: no
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
1551, 2084, 2365, 2682, 3259 ppm.
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days (or other?)
- Frequency of observations and weighing: daily. Weighted at 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology.

Results and discussion

Effect levelsopen allclose all
Sex:
male
Dose descriptor:
LC50
Effect level:
2 231 ppm
95% CL:
1 938 - 2 568
Exp. duration:
4 h
Sex:
female
Dose descriptor:
LC50
Effect level:
2 518 ppm
95% CL:
2 268 - 2 796
Exp. duration:
4 h
Mortality:
Males: 0/5, 1/5, 3/5, 5/5, 4/5 at each dose. For females, none died up to 2365ppm, all died at 2682ppm and above.
Clinical signs:
other: At approximately the LC50 concentration, animals exhibited hind leg paralysis in 7/20 animals post exposure. Hypereactivity, tremors, and convulsions also reported.
Body weight:
Decreased body weight was seen at 2084ppm but not at 1581ppm.
Gross pathology:
No gross pathology was reported..

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The 4-hr LC50 value indicates a moderate degree of vapor toxicity. At these high vapor concentration, signs are predominantly those of a central excitatory nature, particularly hypereactivity, tremors, and convulsions.
Executive summary:

In a reliable study, Ballantyne et al (1997) published acute 4 -hr LC50 values of 2231 ppm (11.2 mg/l) (males) and 2518 ppm (12.6 mg/l) (females) for vinyl norbornene vapor in rats.